MEIDAM – House of Dermatology

General Abstract Submission – Non-Residents Only
(Both Oral & Poster type)

You are invited to submit an abstract for the 9th International Congress of Medical Excellence in Dermatology & Aesthetic Medicine, to be held on 15 -17 November 2024, at the Dubai World Trade Centre, Sheikh Rashid Hall & Sheikh Maktoum Hall, Dubai, United Arab Emirates.

To submit an abstract, please read all of the instructions below:

  • Abstract submission opens on 15th January 2024 – Deadline is 30th April 2024
  • Final Call 15th April 2024
  • Notification of acceptance / Rejection – 30th May 2024
  • Review Timeline 30 days
  • Final Program Announcement 15th June 2024
  • Language

All abstracts must be submitted in English using the online submission form on the MEIDAM Congress website.

  • Abstracts are required for all presentations.
  • Abstracts must be submitted maximum by Friday, 15 March 2024 (23:59 GMT).
  • Abstracts must be submitted in English.
  • It is possible to withdraw an abstract within 14 days from notification on acceptance mail, through a withdrawal of abstracts notification in writing.
  • If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
  • An Oral Abstracts submission when not accepted for Oral Presentation are provided the opportunity to present it as a Poster. The presenter may either accept to present it as a poster or withdraw their abstract if not applicable to present as a poster.
  • Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
  • Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
  • Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
  • All approved presenters will be registered to the congress. Only 1 abstract presenter will receive free registration for each accepted abstract to attend the congress. Any additional presenters or co-authors for the same abstract should register themselves to attend the congress.
  • Abstract submitters must consent to the policies of Abstract Submission.
  • Scientific committee reserves the right to exclude any abstract from the scientific program that does not follow appropriate guidelines as mentioned.

Original works and Case Reports about Dermatology & Aesthetic Medicine will be accepted.

The abstract text body is limited to 3,000 characters (Approx. 500 words) including spaces. (Please do not include the title and the author’s information in the text body (names and affiliations), this information will be required in the web form).

The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS.

No full stop at the end.

There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.

 

The abstract must include the following:

Aim
Clearly state the purpose of the abstract.
Methods
Describe your selection of observations or experimental subjects clearly.
Results
Present your results in a logical sequence in text, table and illustrations.
Conclusions
Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.

All abbreviations must be defined in first use.

No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.

Statements such as “results will be discussed” or “data will be presented” cannot be accepted.

Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. scientific committee reserves the right to replace any brand name with a generic name without further notice.

Images that are uploaded to follow the abstract are not guaranteed inclusion in the congress materials.

Recent Comments
    Archives
    Categories